Article Archive
Pfizer/Trovan trial in Nigeria adjourned
20 October 2008
USA's CDC awards $16.9M contract to ATCC
20 October 2008
Indian pharma sector deals for SOHM
20 October 2008
"Huge opportunity for Indian talent"
20 October 2008
Exjade cuts thalassemia iron build up in organs
20 October 2008
Merz' tinnitus drug enters Ph III testing
20 October 2008
FDA nod for Seroquel XR in bipolar disorder
20 October 2008
FDA approval for new Risperdal injection site
20 October 2008
Bayer's Factor VIII drug gets FDA go-ahead
20 October 2008
Lev gets OK for Cinryze ahead of merger
20 October 2008
Rotateq wins WHO pre-qualification status
20 October 2008
EC approves Shire/Jerini's Firazyr
20 October 2008
Daiichi Sankyo plans to become a leader in antithrombotics with prasugrel and DU-176b
20 October 2008
Acai antioxidants absorbed by body
20 October 2008
Meta-analysis questions probiotics use in eczema
20 October 2008
ACG hears strong data for probiotics in IBS
20 October 2008
Pfizer's Zyvox could be "ray of hope" for drug-resistant TB
20 October 2008
Processed cocoa powder still rich in antioxidants
20 October 2008
Heparins could fight lung cancer, says study
20 October 2008
Rifampicine improves compliance says trial
20 October 2008
Ph III data for Sanofi's intradermal flu vacc
20 October 2008
PCD may affect 10-times more than was thought
20 October 2008
New firm will sequence genome for $5,000
20 October 2008
Proteome revenue up 400% on TMT deal
20 October 2008
Epistem's loss deepens on rising R&D costs
20 October 2008
Lorus falls into loss on almost no turnover
20 October 2008
Strong data for iSONEP in AMD mouse model
20 October 2008
Biovest strong Ph III data for BiovaxID
20 October 2008
NPS' Gattex reduces PN dependence in SBS
20 October 2008
Ferring drug better in knee OA than IA-saline
20 October 2008
Alogliptin delayed due to lack of FDA resources
20 October 2008
Biogen Idec drops RA drug on poor Ph II data
20 October 2008
3,000 on-line trial reports needed pa, FDA claims
20 October 2008
US CDC satisfied with 25% HPV vacc coverage
20 October 2008
US CHPA proposal "will not protect children"
20 October 2008
Criticism of US e-Rxing due to lack of standard
20 October 2008
Pharma "a nice juicy target" for "Pres" Obama, DTC expert claims, TV and social media hit
20 October 2008
Circassia acquires rights to dopexamine from Ipsen
13 October 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
Halcygen completes first pivotal SUBA-itraconaole trial
13 October 2008
B-MS backs off higher offer for ImClone
13 October 2008
Norway track-and-trace for Rx drugs
13 October 2008
Japan MHLW Study C'ttee views developments
13 October 2008
CombinatoRx' Synavive disappoints in Ph II trial
13 October 2008
OPKO gets rights to Teva's budesonide
13 October 2008
Merck & Co stops taranabant at Ph III
13 October 2008
Amarin swings to profit on financing round
13 October 2008
Genesis reports almost flat income in 2008
13 October 2008
SkyePharma renegotiates convertible bonds for L18.4M
13 October 2008
Perrigo acquires Laboratorios Diba for $25M
13 October 2008
Grifols breaks ground on new IVIG facility
13 October 2008
BT Pharma makes Thierry Hercend chairman
13 October 2008
IPHA names Gerald Farrell as president
13 October 2008
US FDA has approved Reyataz plus ritonavir combo for HIV-1
13 October 2008
Sirion launches Durezol in USA
13 October 2008
Celgene
13 October 2008
Galenea and Otsuka extend schizophrenia R&D accord
13 October 2008
Abbott opens new research/pilot facility in Ludwigshafen
13 October 2008
Brazil pharma growth set for 21.5% in 2008
13 October 2008
Watson's Rapaflo approved by US FDA
13 October 2008
BioXcel views next phase of growth
13 October 2008
Japan sees growth in nicotine patch market
13 October 2008
Cenomed/TorreyPines in licensing deal
13 October 2008
Stock Commentary - New York week to Oct 6, 2008
13 October 2008
China is best Big Pharma outsourcing location
13 October 2008
Largest fake drug haul in Europe from India
13 October 2008
NSAIDs reduce breast cancer link 21%
13 October 2008
World neglected tropical disease round-up
13 October 2008
Newron gets 5M-euro govt contract
13 October 2008
India's hep C market set to grow to $171M by 2012
13 October 2008
AtheroGenics files for Chapter 11 bankruptcy
13 October 2008
Potential new use for rituximab in CLL
13 October 2008
Study supports tablet form of Panacos' bevirimat
13 October 2008
US FDA and PATH-MVI collaborate
13 October 2008
UPLIFT data causes stir at Berlin ERS
13 October 2008
Novartis' Xolair shows results in children
13 October 2008
Novartis PAH Glivec trial misses Ph II endpoint
13 October 2008
Sosei/Vectura drug may act faster than Spiriva
13 October 2008
Pfizer denies Neurontin data was "manipulated"
13 October 2008
Expert updates on current CF pipeline
13 October 2008
USA should learn from EMEA biogeneric rules
13 October 2008
France Biotech reviews state of the market
13 October 2008
US think-tank hits out at stars' vaccine myths
13 October 2008
Bayer's riociguat to enters Ph III testing
13 October 2008
UPDATE: Roche offers discount to UK NHS for Tarceva
13 October 2008
NCCN to test Abraxane for SPARC benefits
13 October 2008
Roche/Genentech license GlycArt's GA101
13 October 2008
Lilly acquires Deciphera program in $130M deal
13 October 2008
Lilly pays $62M to end Zyprexa investigation
13 October 2008
Pfizer to establish three new operating units
13 October 2008
Alnylam earns $20M Takeda milestone
13 October 2008
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
